Table 6.
Description | Total population* | Never smokers only in household† | Current cigarette smokers only in household‡ |
---|---|---|---|
Lifetime cumulative risk of death from lung cancer (% per person) | |||
Pre-remediation | 7.13 | 0.94 | 28.52 |
Post-remediation | 6.09 | 0.80 | 24.81 |
Health gain per 1000 households remediating | |||
Lung cancer cases averted | 25.1 | 3.4 | 89.2 |
Total QALYs gained§ | 136.3 | 20.2 | 352.3 |
Resource use and costs per household remediating§ | |||
Invitation, measurement, and remediation costs | 3414 | 3414 | 3414 |
NHS lung cancer treatment costs averted | 126 | 17 | 447 |
Other NHS costs incurred by added life expectancy | 774 | 110 | 1870 |
Net cost—societal | 4062 | 3506 | 4836 |
Cost effectiveness§ | |||
Cost per QALY gained—societal: | 29 789 | 173 720 | 13 727 |
To NHS | 4752 | 4590 | 4037 |
To homeowners, Health Protection Agency, and government departments | 25 037 | 169 130 | 9690 |
QALY=quality adjusted life year.
*Calculated using age specific and sex specific lung cancer death rates for entire UK population.
†Calculated using age specific and sex specific lung cancer death rates for a population of lifelong non-smokers.19
‡Calculated using age specific and sex specific deaths from lung cancer for current cigarette smokers in UK. Rates were derived from observed age specific and sex specific lung cancer death rates for 2006 for the total UK population, estimates of lung cancer death rates for lifelong non-smokers,19 estimates of relative risks for UK men with differing smoking habits compared with continuing cigarette smokers,20 and estimates of proportion of population according to smoking status for categories of age and sex.21 31
§Discounted.